Results 61 to 70 of about 1,641 (192)

Emerging antibiotics for community-acquired pneumonia [PDF]

open access: yes, 2019
Introduction: Community-acquired pneumonia is the most common infection leading to hospitalization and death in all age groups, especially in elderly populations.
Cillóniz, Catia   +3 more
core   +1 more source

REVIEW ON CLINICALLY DEVELOPING ANTIBIOTICS [PDF]

open access: yes, 2018
The world is running out of antibiotics. Between 1940 and 1962, more than 20 new classes of antibiotics were marketed. Since then, only two new classes of antibiotics were marketed.
M., Sudha   +3 more
core   +3 more sources

FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022 [PDF]

open access: yes, 2023
The inclusion of fluorine atoms or heterocyclic moiety into drug structures represents a recurrent motif in medicinal chemistry. The combination of these two features is constantly appearing in new molecular entities with various biological activities ...
Amata S.   +5 more
core   +1 more source

Linezolid and Rifampicin Combination to Combat cfr-Positive Multidrug-Resistant MRSA in Murine Models of Bacteremia and Skin and Skin Structure Infection. [PDF]

open access: yes, 2019
Linezolid resistance mediated by the cfr gene in MRSA represents a global concern. We investigated relevant phenotype differences between cfr-positive and -negative MRSA that contribute to pathogenesis, and the efficacy of linezolid-based combination ...
Li, Liang   +6 more
core  

Synthesis of an Enzyme‐Triggered Chitosan‐Based Drug Delivery System for Peri‐Implantitis Prevention

open access: yesChemistry – A European Journal, Volume 32, Issue 16, 25 April 2026.
ABSTRACT Dental implants have become a leading solution for tooth loss, yet bacterial infections remain a major complication. Antibacterial implant coatings are an important approach to reduce or prevent bacterial infections at the implant. Given the oral cavity's complex microbiome and the importance of some commensal bacteria, it is crucial to ...
Nelly Senze Nnane   +7 more
wiley   +1 more source

Determination of Delafloxacin in Pharmaceutical Formulations Using a Green RP-HPTLC and NP-HPTLC Methods: A Comparative Study

open access: yesAntibiotics, 2020
In this work; delafloxacin (DLFX) was determined using a validated green RP-HPTLC and NP-HPTLC methods in commercial tablets and in-house developed solid lipid nanoparticles (SLNs).
Prawez Alam   +7 more
doaj   +1 more source

Estimating Renal Function in Drug Development: Time to Take the Fork in the Road [PDF]

open access: yes, 2019
Renal function is the most commonly applied patient‐specific quantitative variable used to determine drug doses. Measurement of renal function is not practical in most clinical settings; therefore, clinicians often rely on estimates when making dosing ...
Accetta   +34 more
core   +1 more source

New antibiotics for the treatment of acute bacterial skin and soft tissue infections in pediatrics [PDF]

open access: yes, 2020
Acute bacterial skin and soft tissue infections (aSSTIs) are a large group of diseases that can involve exclusively the skin or also the underlying subcutaneous tissues, fascia, or muscles.
Argentiero A.   +4 more
core   +2 more sources

Frontiers in the Management of Orthopaedic Periprosthetic Joint Infection

open access: yesJournal of Orthopaedic Research, Volume 44, Issue 2, February 2026.
ABSTRACT Periprosthetic joint infection (PJI) is a devastating complication of total joint arthroplasty (TJA), one of the most frequently performed surgical procedures worldwide. Management of acute PJI commonly involves debridement, antibiotics, and implant retention (DAIR), though failure rates remain high due to antibiotic‐tolerant biofilms. Chronic
Michael F. Shannon   +9 more
wiley   +1 more source

Ciprofloxacin-Resistant Pseudomonas aeruginosa Lung Abscess Complicating COVID-19 Treated with the Novel Oral Fluoroquinolone Delafloxacin

open access: yesCase Reports in Pulmonology, 2022
Purpose. We report the development of a lung abscess caused by a ciprofloxacin-resistant Pseudomonas aeruginosa in a patient with COVID-19 on long-term corticosteroid therapy.
Jürgen Panholzer   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy